Who is sponsoring NCT01642238?

NCT01642238 is sponsored by Juan J Badimon.

What condition does NCT01642238 study?

NCT01642238 studies Acute Coronary Syndrome.

What drugs are being tested in NCT01642238?

Interventions: Ticagrelor + ASA + Bivalirudin, Clopidogrel + ASA + Bivalirudin.

What is the status of NCT01642238?

NCT01642238 is currently COMPLETED.

Last reviewed 2016-06-01 · How we verify

Randomized, Crossover Study of the Antithrombotic Effects of Ticagrelor Plus Aspirin Versus Clopidogrel Plus Aspirin When Administered With Bivalirudin

NCT01642238 Phase 4 COMPLETED Results posted

The purpose of this study is to determine whether treatment with ticagrelor (plus aspirin and bivalirudin) is more effective than treatment with clopidogrel (plus aspirin and bivalirudin).

Details

Lead sponsor	Juan J Badimon
Phase	Phase 4
Status	COMPLETED
Enrolment	15
Start date	2012-07
Completion	2013-04

Conditions

Acute Coronary Syndrome

Interventions

Ticagrelor + ASA + Bivalirudin
Clopidogrel + ASA + Bivalirudin

Primary outcomes

Platelet-thrombus Formation in an ex Vivo Model of Thrombosis — Pre-treatment baseline and 1 hour
Change in thrombus size at 1 hour as compared to Pre-treatment baseline, where a positive change represents a decrease in thrombus size.
Platelet-thrombus Formation in an ex Vivo Model of Thrombosis — Pre-treatment baseline and 24 hrs post treatment
Change in thrombus size at 24 hours as compared to Pre-treatment baseline, where a positive change represents a decrease in thrombus size.

Countries

United States